Market Overview:
The global chymotrypsin for injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for chymotrypsin for various applications, such as application I and application II. Chymotrypsin is a proteolytic enzyme that helps in the digestion of proteins. It is used as an ingredient in various food items and also has medical applications.
Product Definition:
Chymotrypsin for Injection is a proteolytic enzyme isolated from the pancreas. Chymotrypsin cleaves peptide bonds adjacent to certain amino acids, including tyrosine, phenylalanine and tryptophan. Chymotrypsin is used as a digestive aid to help digest proteins in the stomach.
Powder:
Powder is a combination of chymotrypsinogen and other ingredients which are used as an alternative to the enzyme's activity. It can be formulated in various forms such as lyophilized, non-lyophilized, and ready to use solutions. Powder is majorly used for the treatment of dogs suffering from acute pancreatitis or chronic pancreatitis.
Particle:
Particle and it's usage in Chymotrypsin for Injection market is used in the process of digestion by the body. The particles are basically used to enhance the absorption of chymotrypsinogen from stomach into blood and other tissues. It basically increases the amount of enzyme that can be utilized during a particular time period which ultimately improves digestive function.
Application Insights:
Application I accounted for the largest share of more than 60.0% in 2017. The application is majorly used to treat chronic kidney diseases and other disorders. Chronic Kidney Disease (CKD) is a condition in which the kidneys are not able to function properly over a period of time leading to increased blood flow through the kidneys and reduced urine output from the body tissues. Chymotrypsin for injection is widely used as an alternative therapy for treating patients with CKD as it helps remove waste products from cells, thus improving renal function naturally without any side effects or adverse reactions reported so far among patients undergoing treatment with this enzyme replacement therapy product globally.
Application II segment is expected to witness significant growth during forecast years due largely on increasing R&D initiatives by various companies operating in this sector including Pfizer, Merck & Co., Inc.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing healthcare expenditure are some of the factors responsible for its growth. In addition, new product launches and technological advancements are also expected to drive the regional market over the forecast period. For instance, in May 2018 Merck KGaA launched chymotrypsinogen IX (KYXnine) that is a purified form of chicken trypsin inhibitor under brand name KYNA gel for treatment of IBS-C (irritable bowel syndrome with constipation).
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising disposable income leading to an increase in demand for medical products & services; growing geriatric population prone to chronic diseases; and increasing awareness about early diagnosis among patients.
Growth Factors:
- Increasing demand for Chymotrypsin for Injection due to its therapeutic properties.
- Rising prevalence of chronic diseases that can be treated with Chymotrypsin for Injection.
- Growing awareness about the benefits of Chymotrypsin for Injection among patients and healthcare professionals.
- Technological advancements in the manufacturing of Chymotrypsin for Injection products that improve their quality and efficacy.
Scope Of The Report
Report Attributes
Report Details
Report Title
Chymotrypsin for Injection Market Research Report
By Type
Powder, Particle, Other
By Application
Application I, Application II
By Companies
BIOZYM, Worthington Biochemical Corporation, Sigma-Aldrich, Shanghai Yaxin Biotechnology, Atlanta Biologicals, Sichuan Deebio Pharmaceutical, BeiJing Geyuantianrun Bio-tech, Shanghai Linzyme Biosciences, Zhejiang Fengan Biopharmaceutical, Gold Bio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Chymotrypsin for Injection Market Report Segments:
The global Chymotrypsin for Injection market is segmented on the basis of:
Types
Powder, Particle, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Application I, Application II
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BIOZYM
- Worthington Biochemical Corporation
- Sigma-Aldrich
- Shanghai Yaxin Biotechnology
- Atlanta Biologicals
- Sichuan Deebio Pharmaceutical
- BeiJing Geyuantianrun Bio-tech
- Shanghai Linzyme Biosciences
- Zhejiang Fengan Biopharmaceutical
- Gold Bio
Highlights of The Chymotrypsin for Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder
- Particle
- Other
- By Application:
- Application I
- Application II
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Chymotrypsin for Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Chymotrypsin is a serine protease enzyme that is used to dissolve proteins. It is most commonly used as an injection for the treatment of pancreatitis, cholangitis, and other diseases of the liver.
Some of the key players operating in the chymotrypsin for injection market are BIOZYM, Worthington Biochemical Corporation, Sigma-Aldrich, Shanghai Yaxin Biotechnology, Atlanta Biologicals, Sichuan Deebio Pharmaceutical, BeiJing Geyuantianrun Bio-tech, Shanghai Linzyme Biosciences, Zhejiang Fengan Biopharmaceutical, Gold Bio.
The chymotrypsin for injection market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Chymotrypsin for Injection Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Chymotrypsin for Injection Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Chymotrypsin for Injection Market - Supply Chain
4.5. Global Chymotrypsin for Injection Market Forecast
4.5.1. Chymotrypsin for Injection Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Chymotrypsin for Injection Market Size (000 Units) and Y-o-Y Growth
4.5.3. Chymotrypsin for Injection Market Absolute $ Opportunity
5. Global Chymotrypsin for Injection Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Chymotrypsin for Injection Market Size and Volume Forecast by Type
5.3.1. Powder
5.3.2. Particle
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Chymotrypsin for Injection Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Chymotrypsin for Injection Market Size and Volume Forecast by ApplicationIII
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Chymotrypsin for Injection Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Chymotrypsin for Injection Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Chymotrypsin for Injection Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Chymotrypsin for Injection Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Chymotrypsin for Injection Demand Share Forecast, 2019-2029
9. North America Chymotrypsin for Injection Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Chymotrypsin for Injection Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Chymotrypsin for Injection Market Size and Volume Forecast by ApplicationIII
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Chymotrypsin for Injection Market Size and Volume Forecast by Type
9.7.1. Powder
9.7.2. Particle
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Chymotrypsin for Injection Demand Share Forecast, 2019-2029
10. Latin America Chymotrypsin for Injection Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Chymotrypsin for Injection Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Chymotrypsin for Injection Market Size and Volume Forecast by ApplicationIII
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Chymotrypsin for Injection Market Size and Volume Forecast by Type
10.7.1. Powder
10.7.2. Particle
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Chymotrypsin for Injection Demand Share Forecast, 2019-2029
11. Europe Chymotrypsin for Injection Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Chymotrypsin for Injection Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Chymotrypsin for Injection Market Size and Volume Forecast by ApplicationIII
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Chymotrypsin for Injection Market Size and Volume Forecast by Type
11.7.1. Powder
11.7.2. Particle
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Chymotrypsin for Injection Demand Share, 2019-2029
12. Asia Pacific Chymotrypsin for Injection Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Chymotrypsin for Injection Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Chymotrypsin for Injection Market Size and Volume Forecast by ApplicationIII
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Chymotrypsin for Injection Market Size and Volume Forecast by Type
12.7.1. Powder
12.7.2. Particle
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Chymotrypsin for Injection Demand Share, 2019-2029
13. Middle East & Africa Chymotrypsin for Injection Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Chymotrypsin for Injection Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Chymotrypsin for Injection Market Size and Volume Forecast by ApplicationIII
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Chymotrypsin for Injection Market Size and Volume Forecast by Type
13.7.1. Powder
13.7.2. Particle
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Chymotrypsin for Injection Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Chymotrypsin for Injection Market: Market Share Analysis
14.2. Chymotrypsin for Injection Distributors and Customers
14.3. Chymotrypsin for Injection Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. BIOZYM
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Worthington Biochemical Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sigma-Aldrich
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Shanghai Yaxin Biotechnology
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Atlanta Biologicals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sichuan Deebio Pharmaceutical
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. BeiJing Geyuantianrun Bio-tech
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Shanghai Linzyme Biosciences
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Zhejiang Fengan Biopharmaceutical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Gold Bio
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
